Under construction – not a live service
Sign in
Taking people in CanadaNo phase

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

Key facts

Where
Hamilton, Montreal, and Ottawa, CanadaSee the 3 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you 18 years old or older?
  • Are you planning to have, or have you had, an operation to remove part of your liver?
  • Has a doctor told you that the part of your liver that would be left after surgery may be too small?

Source: NCT07717437, who can take part

Where in Canada

  • Juravinski Hospital and Cancer CentreHamilton, CanadaTaking people
  • McGill University Health CentreMontreal, CanadaTaking people
  • The Ottawa HospitalOttawa, CanadaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Maastricht University Medical Center
Trial code
NCT07717437
Record updated
21 July 2026
Original description
The DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver regeneration compared to standard PVE. This collaborative registry focuses on identifying associations between baseline clinical/imaging parameters, clinical outcomes, and safety for patients undergoing PVE/HVE.Read full original descriptionShow less

The DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver regeneration compared to standard PVE. This collaborative registry focuses on identifying associations between baseline clinical/imaging parameters, clinical outcomes, and safety for patients undergoing PVE/HVE.

Inclusion: Patients who have undergone PVE/HVE or technical variations on this procedure; 18 Years and older; Men and women.

ClinicalTrials.gov NCT07717437